Congress of psychiatry

002
  Empowering service users: assessing the poten-
tial benefits of psychiatric genetic counselling from 
the first UK pilot study
Melanie Watson, United Kingdom
J. C. Austin
003
  Goethe's creative (self-)therapeutic strategies to 
overcome depressive episodes
Rainer M. Holm-Hadulla, Germany
004
  New findings on the use of the Italian adaptation 
of the family quality of life survey
Michele Rossi, Italy
Elisa Rondini, Annamaria Bianco, Daniela Scuticchio, 
Giulia Vannucchi, Marco Bertelli
005
  Assessment of pain malingering
Zack Z. Cernovsky, Canada
Jack R. Ferrari
KN-24 
Keynote Lecture
10:00 – 11:00
 | 
Hall B
 
TOPIC 16:
 Diagnostics and classification, 
psychopathology, RDoC
New trends in the classification of mental disor-
ders? DSM-5, ICD-11 and beyond
Chairs: 
Mario Maj, Italy 
Peter Falkai, Germany
Speaker: 
Wolfgang Gaebel, Germany
KN-25 
Keynote Lecture
10:00 – 11:00
 | 
Hall  A6 / A7
 
TOPIC 36:
 Social determinants of mental health
Women's mental health and gender sensitive inter-
ventions
Chairs: 
Donna E. Stewart, Canada 
Iris Hauth, Germany
Speaker: 
Prabha S. Chandra, India
KN-26 
Keynote Lecture
10:00 – 11:00
 | 
Room M8
TOPIC 35:
 Psychiatry and society
 
Situation der Familien
Chairs: 
Martin Driessen, Germany 
Sabine Köhler, Germany
Speaker: 
Gudrun Schliebener, Germany
ME-05 Meet-the-Expert
10:00 – 11:00
 | 
Room  M2 / M3
TOPIC 25:
 Training and continuing education
Personal and not so personal anniversaries
Chairs: 
Jakob Kaminski, Germany 
Mariana Pinto da Costa, Portugal
Speaker: 
Norman Sartorius, Switzerland
PR-05 
Presidential Symposium
10:00 – 11:30
 | 
Hall A8
 
TOPIC 17:
 Psychotherapy
Psychotherapy: third wave of cognitive behavioural 
therapies
Chairs: 
Paul Summergrad, USA 
Fritz Hohagen, Germany
001
  Cognitive science and cognitive therapy: mental 
imagery and mental health
Emily Holmes, Sweden
002
  Metacognitive therapy: effectiveness and  
mechanisms of recovery
Adrian Wells, United Kingdom
003
  Letting go – common elements in cognitive 
psychotherapies
Paul Summergrad, USA
ST-19 (d) 
State-of-the-Art-Symposium
10:00 – 11:30
 | 
Hall A1
 
TOPIC 8:
 Disorders closely related to childhood and 
adolescence
 
Tic-Störungen
Chairs: 
Kirsten Müller-Vahl, Germany 
Irene Neuner, Germany
001
  Tourette-Syndrom und Tics – Klinik und  
Verhaltenstherapie
Kirsten Müller-Vahl, Germany
002
  Tourette-Syndrom und Tics – Therapieoptionen 
medikamentös und mittels tiefer Hirnstimulation
Irene Neuner, Germany

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
SCIENTIFIC
 PROGRAMME
176
ST-20 (d) 
State-of-the-Art-Symposium
10:00 – 11:30
 | 
Hall A4
 
TOPIC 3:
 Psychotic disorders
 
Schizophrenie – Pharmakotherapie
Chairs: 
Martin Lambert, Germany 
W. Wolfgang Fleischhacker, Austria
001
  Erwünschte Wirkungen von Antipsychotika
Martin Lambert, Germany
002
  Unerwünschte Wirkungen von Antipsychotika
W. Wolfgang Fleischhacker, Austria
S-240 Symposium
10:00 – 11:30
 | 
Hall A2
 
TOPIC 27:
 Religion and spirituality
Terrorism, religion and culture from a psychiatric 
perspective
›
 WPA Section: Early Career Psychiatrists
›
 WPA Section: Forensic Psychiatry
›
 WPA Section: Religion, Spirituality and Psychiatry
Chairs: 
Hussien Elkholy, Egypt 
Nahla Nagy, Egypt
001
  Psychological aspects of religious terrorism
Nahla Nagy, Egypt
002
  Forensic psychiatric aspects of terrorism in 
Germany
Norbert Konrad, Germany
003
  Socialization, radicalisation, terrorism
Thomas Stompe, Austria
004
  Training in and for psychiatry – when times are 
bitter
Ekin Sönmez, Turkey
S-241 Symposium
10:00 – 11:30
 | 
Hall Helsinki 1
 
TOPIC 14:
 Neurobiology and genetics
Psychosocial and genetic determinants of brain 
structure and activation
Chairs: 
Hans Jörgen Grabe, Germany 
Andreas Meyer-Lindenberg, Germany
001
  The effects of genetic and environmental risk 
for mental illness on the brain
Tilo Kircher, Germany
002
  Effects of polygenic risk for schizophrenia on 
brain structure
Henrik Walter, Germany
003
  Neurogenetic and pharmacological effects on 
connectomic intermediate phenotypes for schizo-
phrenia
Andreas Meyer-Lindenberg, Germany
004
  Brain ageing, childhood trauma and polygenetic 
factors
Hans Jörgen Grabe, Germany
S-242 Symposium
10:00 – 11:30
 | 
Hall Helsinki 2
 
TOPIC 7:
 Personality disorders
Advances in the treatment of personality disorder
›
 WPA Section: Personality Disorders
Chairs: 
Mike Crawford, United Kingdom 
Sabine C. Herpertz, Germany
001
  Current evidence for psychological interven-
tions: updated Cochrane review
Eric Simonsen, Denmark
002
  Socio-cultural aspects of the clinical management 
of personality disorders
Renato Alarcon, USA
003
  Abnormal brain mechanisms as targets of  
psychotherapy in borderline
Sabine C. Herpertz, Germany
004
  Role of mood stabilizers in treatment of  
personality disorder
Mike Crawford, United Kingdom
S-243 Symposium
10:00 – 11:30
 | 
Hall Paris 1
 
TOPIC 20:
 Prevention and health promotion
Improving outcome in psychiatry by implementing 
youth mental health and early intervention: success 
stories from Australia, the U.S., and Denmark
Chairs: 
Andreas Bechdolf, Germany 
Arno Deister, Germany
001
  Headspace – Australia's innovation in youth 
mental health
Patrick McGorry, Australia
002
  RAISE 2.0 – establishing a national early  
psychosis intervention network in the U.S.
Robert Heinssen, USA
003
  Follow on from the OPUS trial: implementing 
early intervention in psychoses in Denmark
Merete Nordentoft, Denmark
Nikolai Albert, Carsten Hjorthøj, Marianne Melau,  
Anne A. E. Thorup, Ole Mors

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
 German language Session 
 Q & A  Modul
SCIENTIFIC
 PROGRAMME
177
S-244 Symposium
10:00 – 11:30
 | 
Hall Paris 2
 
TOPIC 23:
 Health care research and models, health care 
policy
Family interventions in interdisciplinary psychiat-
ric settings – perinatal psychiatry and behaviour 
addictions
Chairs: 
Tamas Kurimay, Hungary 
Akram K. Wilson, United Kingdom
001
  Perinatal psychiatry – the importance of  
fathers: twelve years of experience of the first  
baby-mother-father-unit in Hungary
Tamas Kurimay, Hungary
Eva Hegedus, Agnes Hortobagyi, Tunde Nemeth
002
  Family intervention: integrated parent-infant 
consultations – case presentations from pre-, peri-, 
and postnatal mental disorders prevention and 
treatment program in Hungary
Eva Hegedus, Hungary
Tunde Nemeth, Vera Tory, Eszter Babus, Tamas Kurimay
003
  Gambling disorder: a family treatment possibility
Massimo Clerici, Italy
Silvia Ronzitti, Ester di Giacomo
S-245 Symposium
10:00 – 11:30
 | 
Hall Berlin 1
 
TOPIC 18:
 Pharmacotherapy
The emerging role of pharmacogenomics in depres-
sion precision medicine
Chairs: 
Mark Frye, USA 
Julia Stingl, Germany
001
  Genetic variability of drug-metabolizing  
enzymes: the dual impact on psychiatric therapy 
and regulation of brain function
Julia Stingl, Germany
002
  Pharmacogenomic regulatory warning labels in 
depression treatment
Simon Kung, USA
003
  Clinical risk factors and serotonin transporter 
gene variants associated with antidepressant- 
induced mania
Mark Frye, USA
004
  Pharmacogenomics of Venlafaxine in older 
adults: analyses from the IRL-GREY trial
Daniel Mueller, Canada
S-246 Symposium
10:00 – 11:30
 | 
Hall New York 1
 
TOPIC 4:
 Affective disorders
The gut brain connection in psychiatry
›
 WPA Section: Affective Disorders
Chairs: 
Gregor Hasler, Switzerland 
Undine Lang, Switzerland
001
  Acute effects of glucose and fructose on behavior 
and brain function
Stefan Borgwardt, Switzerland
002
  The gut brain connection in eating disorders
Gregor Hasler, Switzerland
003
  Metabolic effects of antidepressants: effect or 
side effect?
Undine Lang, Switzerland
004
  The vagus nerve, nutrition and psychiatry
Sigrid Breit, Germany
S-247 Symposium
10:00 – 11:30
 | 
Hall New York 3
 
TOPIC 22:
 Community and social psychiatry
Status of women and mental health in Turkey
Chairs: 
R. Peykan Gökalp, Turkey 
Yildiz Akvardar, Turkey
001
  Women's issues and mental health in Turkey
Yildiz Akvardar, Turkey
002
  Women's shelters in Turkey
Sibel Koçbiyik, Turkey
003
  Women refugees and mental health
Nese Direk, Turkey
004
  Violence and murders against women:  
Turkey case
Zerrin Oglagu, Turkey
S-248 Symposium
10:00 – 11:30
 | 
Hall London 1
 
TOPIC 28:
 History, art and cultural sciences
Creativity and culture in psychiatric disorders – 
treatments
›
 WPA Section: Psychoanalysis in Psychiatry
Chairs: 
Michel Botbol, France 
Carlos Zubaran, Australia
001
  Revisiting the boundaries: art and psychiatry
Carlos Zubaran, Australia

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
SCIENTIFIC
 PROGRAMME
178
002
  Reflecting and being reflected: about artists 
stimulating the therapists' creativity
Ioana Atger, France
003
  Creative mediations with violent adolescents
Adeline Gourbil, France
004
  Wölfli and Morgenthaler: psychoanalytic  
discovery of an insane artist
Jeremie Sinzelle, France
S-249 Symposium
10:00 – 11:30
 | 
Hall London 3
 
TOPIC 22:
 Community and social psychiatry
Intercultural opening in treatment of immigrants 
and ethnic minorities
›
 DGPPN Section: Intercultural Psychiatry and Psycho-
therapy, Migration
›
 EPA – European Psychiatric Association
Chairs: 
Meryam Schouler-Ocak, Germany 
Marianne C. Kastrup, Denmark
001
  EPA – guidance on mental health care of  
immigrants
Iris Tatjana Graef-Calliess, Germany
002
  Cultural competence in mental health care of 
immigrants
Adil Qureshi, Spain
003
  Cultural formulation interview in mental health 
care of immigrants
Hans Rohlof, The Netherlands
004
  Ways of treating immigrants in mental health 
care institutions
Sofie Bäärnhielm, Sweden
S-250 Symposium
10:00 – 11:30
 | 
Room Weimar 3
TOPIC 18:
 Pharmacotherapy
Clozapine revisited: efficacy data, utilisation trends, 
and what to do about clozapine under-prescribing
Chairs: 
Christian Bachmann, Germany 
Dan Siskind, Australia
001
  Is clozapine the most effective anti-psychotic 
for treatment-refractory schizophrenia?
Dan Siskind, Australia
002
  Trends and differences in clozapine utilisation 
in 17 countries worldwide
Christian Bachmann, Germany
003
  Geographical disparities in clozapine utilisation 
in France
Hélène Verdoux, France
004
  Why isn't clozapine prescribed more?
David Taylor, United Kingdom
S-251 Symposium
10:00 – 11:30
 | 
Room Weimar 1
TOPIC 37:
 Stigma and mental health
Joining efforts: relatives, researchers and peers 
against stigma
Chairs: 
Georg Schomerus, Germany 
Patrick W. Corrigan, USA
001
  What can research contribute to anti-stigma 
work?
Patrick W. Corrigan, USA
002
  The relatives' perspective on anti-stigma work
Janine Berg-Peer, Germany
003
  User involvement in anti-stigma work
Stephanie Kay Ventling, Switzerland
004
  25 years of bottom-up anti-stigma work in 
Hamburg – an EU best practice model
Ute Trescher, Germany  
Silke Kühnemund, Germany 
Thomas Bock, Germany
S-252 Symposium
10:00 – 11:30
 | 
Room Lindau 3
TOPIC 1:
 Neurocognitive disorders, organic mental 
disorders, dementia
Subjective cognitive decline and the pre-MCI stage 
of Alzheimer's disease
Chairs: 
Frank Jessen, Germany 
Steffen Wolfsgruber, Germany
001
  Evaluation of subjective cognitive decline (SCD) 
as an early indicator of Alzheimer's disease: design 
and baseline data of the DZNE DELCODE study
Frank Jessen, Germany
002
  Specific neurocognitive impairments in preclin-
ical and prodromal AD
Steffen Wolfsgruber, Germany
003
  Usefulness and stability of multicenter diffu-
sion tensor imaging as an early marker for subjec-
tive cognitive decline and amnestic mild cognitive 
impairment – first results from the prospective 
DZNE DELCODE study
Katharina Brüggen, Germany

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
 German language Session 
 Q & A  Modul
SCIENTIFIC
 PROGRAMME
179
004
  Left frontal hub connectivity ameliorates the 
effects of CSF-tau on memory in amyloid-positive 
non-demented subjects – results from the multi-
center DELCODE study
Nicolai Franzmeier, Germany
Steffen Wolfsgruber, Alfredo Ramirez, Emrah Duezel, 
Michael Wagner, Katharina Buerger, Martin Dichgans, 
Michael Heneka, Peter Falkai, Michael Grothe, Stefan 
Teipel, Jens Wiltfang, Josef Priller, Christoph Laske, Anja 
Schneider, Annika Spottke, Frank Jessen, Michael Ewers
S-253 Symposium
10:00 – 11:30
 | 
Room Lindau 6
TOPIC 16:
 Diagnostics and classification, 
psychopathology, RDoC
Building a science of clinical utility: field studies 
results for ICD-11 mental and behavioural disorders
Chairs: 
María Elena Medina-Mora, Mexico 
Oye Gureje, Nigeria
001
  Case-controlled (internet-based) field studies 
for ICD-11 mental and behavioural disorders: main 
results
Jared Wayne Keeley, USA
002
  Methodology for ecological implementation 
(clinic-based) field studies for ICD-11 mental and 
behavioural disorders
Pratap Sharan, India
003
  Main results of ecological implementation field 
studies for ICD-11 mental and behavioural disorders
María Elena Medina-Mora, Mexico
004
  Regional differences in ecological implemen-
tation field studies results for ICD-11 mental and 
behavioural disorders
Oye Gureje, Nigeria
S-254 Symposium
10:00 – 11:30
 | 
Room Dessau 6
TOPIC 27:
 Religion and spirituality
WPA position statement in religion, spirituality and 
psychiatry: practical implications
›
 WPA Section: Religion, Spirituality and Psychiatry
Chairs: 
Alexander Moreira-Almeida, Brazil 
Peter J. Verhagen, The Netherlands
001
  Presentation of the position statement and its 
practical implications for research, education and 
clinical practice
Alexander Moreira-Almeida, Brazil
002
  Position statement on spirituality and religion 
in psychiatry: a matter of attitude
Peter J. Verhagen, The Netherlands
003
  Impact of the WPA position statement on  
spirituality – religion in psychiatry
Christopher Cook, United Kingdom
004
  Religious interpretation: a blessing or a curse 
in mental health – a practical application of the 
position statement
Driss Moussaoui, Morocco
S-255 Symposium
10:00 – 11:30
 | 
Room R2
TOPIC 34:
 Psychiatry in developing regions
Building human capacity for mental health in low 
and middle income countries
Chairs: 
Samuel Okpaku, USA 
Geetha Jayaram, USA
001
  Barriers and challenges to reducing treatment 
gaps
Samuel Okpaku, USA
002
  Development of community mental health in a 
rural county in Kenya: challenges and opportunities
David Musyimi Ndetei, Kenya
003
  Overcoming cultural and workforce barriers to 
deliver comprehensive mental health care in rural 
southern India using community health workers
Geetha Jayaram, USA
004
  An innovative research capacity building  
program in Mozambique
Milton Wainberg, USA
S-256 Symposium
10:00 – 11:30
 | 
Room R3
TOPIC 21:
 Rehabilitation and work
Functional recovery and return to work or education 
in early psychosis
Chairs: 
Dorothea Jäckel, Germany 
Jürgen Fritze, Germany
001
  School and work: functional recovery pathways 
in first episode psychosis
Eóin Killackey, Australia
002
  Improving functional and clinical recovery by 
combining individual placement and support (IPS) 
and motivational interviewing-based adherence 
therapy (AT) in patients with early psychosis
Dorothea Jäckel, Germany
Andreas Bechdolf, Karolina Leopold, Eva Burkhardt

MOND
A
Y
TUESD
A
Y
WEDNESD
A
Y
THURSD
A
Y
SCIENTIFIC
 PROGRAMME
180
003
  Work is closer than you think – occupational 
recovery of patients with early onset psychosis 
using IPS and CCT
Gesa Döringer, The Netherlands
004
  Self-agency promoting supported employment 
and education in psychosis
Lena Heitmann, Norway
S-257 Symposium
10:00 – 11:30
 | 
Room R13
TOPIC 27:
 Religion and spirituality
Interprofessional collaborations and education  
between mental health and spiritual care profes-
sionals as a pathway for achieving high quality, 
person-centred care
Chairs: 
Wai Lun Alan Fung, Canada 
Avdesh Kumar Sharma, India
001
  Interprofessional collaborations and education 
between mental health and spiritual care profes-
sionals – why, what, when and how?
Wai Lun Alan Fung, Canada
002
  Interfaith mental health alliance for holistic, cost 
effective, culturally sensitive health care delivery
Avdesh Kumar Sharma, India